209 related articles for article (PubMed ID: 23453736)
1. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.
Yin X; Peng J; Zhao L; Yu Y; Zhang X; Liu P; Feng Q; Hu Y; Pang X
Syst Appl Microbiol; 2013 May; 36(3):188-96. PubMed ID: 23453736
[TBL] [Abstract][Full Text] [Related]
2. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.
Zhang X; Zhao Y; Zhang M; Pang X; Xu J; Kang C; Li M; Zhang C; Zhang Z; Zhang Y; Li X; Ning G; Zhao L
PLoS One; 2012; 7(8):e42529. PubMed ID: 22880019
[TBL] [Abstract][Full Text] [Related]
3. Qinghua Fang inhibits high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota.
Wang Y; Lv S; Shen T; Ye M; Wang D; Zhou P; Li Y; Zhang W
Ann Palliat Med; 2021 Mar; 10(3):3219-3234. PubMed ID: 33849107
[TBL] [Abstract][Full Text] [Related]
4. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
5. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
6. Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure.
Wei H; Dong L; Wang T; Zhang M; Hua W; Zhang C; Pang X; Chen M; Su M; Qiu Y; Zhou M; Yang S; Chen Z; Rantalainen M; Nicholson JK; Jia W; Wu D; Zhao L
FEMS Microbiol Ecol; 2010 Sep; 73(3):577-86. PubMed ID: 20629751
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.
De Minicis S; Rychlicki C; Agostinelli L; Saccomanno S; Candelaresi C; Trozzi L; Mingarelli E; Facinelli B; Magi G; Palmieri C; Marzioni M; Benedetti A; Svegliati-Baroni G
Hepatology; 2014 May; 59(5):1738-49. PubMed ID: 23959503
[TBL] [Abstract][Full Text] [Related]
8. Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids.
Liu T; Hougen H; Vollmer AC; Hiebert SM
Anaerobe; 2012 Jun; 18(3):331-7. PubMed ID: 22387300
[TBL] [Abstract][Full Text] [Related]
9. Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids.
Ni Y; Wang X; Wu Q; Yao Y; Xu Y; Li Y; Feng Q; Zhou M; Gou X
Front Endocrinol (Lausanne); 2023; 14():1272214. PubMed ID: 37900123
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
[TBL] [Abstract][Full Text] [Related]
11. Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway.
Liu D; Zhang Y; Liu Y; Hou L; Li S; Tian H; Zhao T
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(8):513-520. PubMed ID: 29365334
[TBL] [Abstract][Full Text] [Related]
12. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis.
Tian Y; Wang H; Yuan F; Li N; Huang Q; He L; Wang L; Liu Z
Biomed Res Int; 2016; 2016():9462571. PubMed ID: 27051672
[TBL] [Abstract][Full Text] [Related]
13. Shifts in microbiota species and fermentation products in a dietary model enriched in fat and sucrose.
Etxeberria U; Arias N; Boqué N; Macarulla MT; Portillo MP; Milagro FI; Martinez JA
Benef Microbes; 2015 Mar; 6(1):97-111. PubMed ID: 25213025
[TBL] [Abstract][Full Text] [Related]
14. Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats.
Feng W; Wang H; Zhang P; Gao C; Tao J; Ge Z; Zhu D; Bi Y
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1801-1812. PubMed ID: 28341485
[TBL] [Abstract][Full Text] [Related]
15. [The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].
Li HS; Feng Q; Hu YY; Chen SD; Peng JH; Li XM; Xu LL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):826-30. PubMed ID: 19958641
[TBL] [Abstract][Full Text] [Related]
16. [Effect of n-3 polyunsaturated fatty acids on gut microbiota and endotoxin levels in portal vein of rats fed with high-fat diet].
Cao ZJ; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):496-500. PubMed ID: 25360646
[TBL] [Abstract][Full Text] [Related]
17. Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.
Compare D; Coccoli P; Rocco A; Nardone OM; De Maria S; Cartenì M; Nardone G
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):471-6. PubMed ID: 22546554
[TBL] [Abstract][Full Text] [Related]
18. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway.
Leng J; Huang F; Hai Y; Tian H; Liu W; Fang Y; Hu Y; Peng J
Phytomedicine; 2020 Jan; 66():153135. PubMed ID: 31790895
[TBL] [Abstract][Full Text] [Related]
20. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.
Islam KB; Fukiya S; Hagio M; Fujii N; Ishizuka S; Ooka T; Ogura Y; Hayashi T; Yokota A
Gastroenterology; 2011 Nov; 141(5):1773-81. PubMed ID: 21839040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
